Rhythm Pharmaceuticals, Inc. (RYTM)

102.74 -2.15 (-2.05%) USD  |  NASDAQ  |  Sep 04, 16:00
102.77 +0.03 (+0.03%) After-Hours: 20:00
More

Rhythm Pharmaceuticals Cash and Short Term Investments (Annual) : 388.95M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RYTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2012. Start Trial.
Date Value
December 31, 2025 388.95M
December 31, 2024 320.56M
December 31, 2023 275.85M
December 31, 2022 333.29M
December 31, 2021 294.86M
December 31, 2020 172.79M
December 31, 2019 292.46M
Date Value
December 31, 2018 252.06M
December 31, 2017 148.08M
December 31, 2016 10.54M
December 31, 2015 34.87M
December 31, 2014 0.152M
December 31, 2013 17.76M
December 31, 2012 17.04M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B
BioMarin Pharmaceutical, Inc. 1.561B
Cytokinetics, Inc. 885.34M
Exelixis, Inc. 1.059B